Cargando…

Exposure-Response Modeling to Support Dosing Selection for Phase IIb Development of Kukoamine B in Sepsis Patients

Aim: Kukoamine B, a small molecule compound, is being developed for the treatment of sepsis in a Phase II clinical trial. The objective of this study was to optimize dosing selection for a Phase IIb clinical trial using an exposure-response model. Methods: Data of 34 sepsis patients from a Phase IIa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Huanhuan, Hu, Xiaoyun, Wang, Teng, Cui, Cheng, Jiang, Ji, Dong, Kai, Chen, Shuai, Jin, Chunyan, Zhao, Qian, Du, Bin, Hu, Pei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091127/ https://www.ncbi.nlm.nih.gov/pubmed/33953679 http://dx.doi.org/10.3389/fphar.2021.645130

Ejemplares similares

Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study
por: Zhao, Qian, et al.
Publicado: (2023)

A Metabolomics Approach to Investigate Kukoamine B—A Potent Natural Product With Anti-diabetic Properties
por: Li, Yuan-Yuan, et al.
Publicado: (2019)

Phase I pharmacokinetic study of an oral, small-molecule MEK inhibitor tunlametinib in patients with advanced NRAS mutant melanoma
por: Zhao, Qian, et al.
Publicado: (2022)

Identification of Kukoamine A, Zeaxanthin, and Clexane as New Furin Inhibitors
por: Zaragoza-Huesca, David, et al.
Publicado: (2022)

Modeling and Simulation to Support Phase Ib/IIa Dose Selection for WBP216, A Long Half-Life Fully Human Monoclonal Antibody Against Interleukin-6
por: Tang, Xiange, et al.
Publicado: (2021)

Kukoamine B promotes TLR4-independent lipopolysaccharide uptake in murine hepatocytes
por: Yang, Dong, et al.
Publicado: (2016)

Antioxidant and Cytoprotective Effects of Kukoamines A and B: Comparison and Positional Isomeric Effect
por: Li, Xican, et al.
Publicado: (2018)

Akt Regulated Phosphorylation of GSK-3β/Cyclin D1, p21 and p27 Contributes to Cell Proliferation Through Cell Cycle Progression From G1 to S/G2M Phase in Low-Dose Arsenite Exposed HaCat Cells
por: Chen, Yao, et al.
Publicado: (2019)

Simplified Dosing Regimens for Gentamicin in Neonatal Sepsis
por: D’Agate, S., et al.
Publicado: (2021)

Influence of oral administration of kukoamine A on blood pressure in a rat hypertension model
por: Butts, Christine A., et al.
Publicado: (2022)

Kukoamine A Improves Mycoplasma pneumoniae Pneumonia by Regulating miR-222-3p/Superoxide Dismutase 2
por: Liu, Xiu-Xiu, et al.
Publicado: (2022)

Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis
por: Chen, Chao‐Yang, et al.
Publicado: (2023)

Dose Rationale for Amoxicillin in Neonatal Sepsis When Referral Is Not Possible
por: D’Agate, Salvatore, et al.
Publicado: (2020)

Migfilin supports hemostasis and thrombosis through regulating platelet aIIbβ3 outside-in signaling
por: Zhou, Yangfan, et al.
Publicado: (2019)

Quality control of Lycium chinense and Lycium barbarum cortex (Digupi) by HPLC using kukoamines as markers
por: Li, Yuan-Yuan, et al.
Publicado: (2017)

Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification
por: Luo, Liying, et al.
Publicado: (2023)

Xinmailong Modulates Platelet Function and Inhibits Thrombus Formation via the Platelet αIIbβ3-Mediated Signaling Pathway
por: Wang, Huawei, et al.
Publicado: (2019)

Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock
por: Borsuk-De Moor, Agnieszka, et al.
Publicado: (2018)

Kukoamine A inhibits human glioblastoma cell growth and migration through apoptosis induction and epithelial-mesenchymal transition attenuation
por: Wang, Qiaoping, et al.
Publicado: (2016)

Correction: Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification
por: Luo, Liying, et al.
Publicado: (2023)

Maternal Methamphetamine Exposure Influences Behavioral Sensitization and Nucleus Accumbens DNA Methylation in Subsequent Generation
por: Dong, Nan, et al.
Publicado: (2022)

Extract of Seaweed Codium fragile Inhibits Integrin αIIbβ3-Induced Outside-in Signaling and Arterial Thrombosis
por: Kim, Tae In, et al.
Publicado: (2021)

Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life Support
por: Wang, Yixue, et al.
Publicado: (2021)

Neuroprotective effects of kukoamine A on 6-OHDA-induced Parkinson's model through apoptosis and iron accumulation inhibition
por: Li, Xin, et al.
Publicado: (2020)

The impact of aspirin exposure prior to intensive care unit admission on the outcomes for patients with sepsis-associated acute respiratory failure
por: Lu, Zongqing, et al.
Publicado: (2023)

Changes in Class I and IIb HDACs by δ-Opioid in Chronic Rat Glaucoma Model
por: Zaidi, Syed A. H., et al.
Publicado: (2020)

Ulmus parvifolia Modulates Platelet Functions and Inhibits Thrombus Formation by Regulating Integrin α(IIb)β(3) and cAMP Signaling
por: Irfan, Muhammad, et al.
Publicado: (2020)

A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese Male Subjects
por: Zhang, Hong, et al.
Publicado: (2021)

Optimal dose of cefotaxime in neonates with early-onset sepsis: A developmental pharmacokinetic model-based evaluation
por: Shang, Zhen-Hai, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection
por: Namour, Florence, et al.
Publicado: (2015)

Population Pharmacokinetic and Exposure–Response Analysis of Finerenone: Insights Based on Phase IIb Data and Simulations to Support Dose Selection for Pivotal Trials in Type 2 Diabetes with Chronic Kidney Disease
por: Snelder, Nelleke, et al.
Publicado: (2019)

Resibufogenin Targets the ATP1A1 Signaling Cascade to Induce G2/M Phase Arrest and Inhibit Invasion in Glioma
por: Zhang, Xun, et al.
Publicado: (2022)

Commentary: Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy
por: Durán, Javier, et al.
Publicado: (2018)

Population Pharmacokinetic/Pharmacodynamic Model-Guided Dosing Optimization of a Novel Sedative HR7056 in Chinese Healthy Subjects
por: Zhou, Ying, et al.
Publicado: (2018)

Kukoamine B Ameliorate Insulin Resistance, Oxidative Stress, Inflammation and Other Metabolic Abnormalities in High-Fat/High-Fructose-Fed Rats
por: Zhao, Quan, et al.
Publicado: (2020)

A Phase I, Randomized, Single-Dose Study Evaluating the Biosimilarity of TAB008 to Bevacizumab in Healthy Volunteers
por: Wang, Jin, et al.
Publicado: (2019)

Corrigendum: Population Pharmacokinetic/Pharmacodynamic Model-Guided Dosing Optimization of a Novel Sedative HR7056 in Chinese Healthy Subjects
por: Zhou, Ying, et al.
Publicado: (2019)

Resveratrol: Potential Application in Sepsis
por: Li, Jiajia, et al.
Publicado: (2022)

Pharmacological Modulation of BET Family in Sepsis
por: Wang, Nian, et al.
Publicado: (2021)

Efficacy and toxicity of image-guided intensity-modulated radiation therapy combined with dose-escalated brachytherapy for stage IIB cervical cancer
por: Wang, Weiping, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tcjbl95sr3s1cou947cp44ht9b